Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Study Could Help Stroke Victims

25.04.2007
A University of Leicester study could help to provide a new lease of life for patients who have suffered a stroke.

The research published in the American Journal of Hypertension confirms the safety of a drug, Lisinopril, that lowers their blood pressure-without reducing the blood flow to the brain.

Now a larger Leicester trial is under way to investigate the drug’s benefits for victims of strokes.

Dr David Eveson, of the Department of Cardiovascular Sciences at the University of Leicester, said: “High blood pressure is common immediately after a stroke. Stroke patients with high blood pressure tend to have a worse outcome than those with normal blood pressure and therefore it may be helpful to lower blood pressure immediately after stroke.

“However, trials to date have shown variable results, probably because treatment was either started too late or the wrong drug was used.

“The ACE inhibitor class of blood pressure lowering drugs, of which Lisinopril is a member, have been shown in studies to lower blood pressure but preserve the blood flow to the brain which may be all important after stroke. This study compared the use of blood pressure lowering with Lisinopril versus placebo treatment within a few hours of acute stroke in patients presenting to University Hospitals Leicester. The results showed that blood pressure was effectively lowered in the treated group and this did not result in any adverse outcome in comparison with placebo.

“The study was too small to demonstrate any benefit but it did confirm safety and thus a larger Leicester-based trial (CHHIPS) is under way to see if this treatment can be of benefit to patients.”

The study is entirely led by the University of Leicester which is in the forefront of international stroke research.

Dr Eveson added: “Stroke is the second commonest cause of death in the UK and the commonest cause of adult disability. It is imperative that we strive to discover new treatments for stroke to reduce the substantial impact of this disease.

“This study evaluates, for the first time, an established blood pressure lowering drug immediately after stroke and confirms its safety in this group, thereby paving the way for larger studies to discover if it may benefit patients.”

Alex Jelley | alfa
Further information:
http://www.le.ac.uk

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>